Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 901–1,000 of 1,035
Song, H., Shen, X., Chu, Q., & Zheng, X. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11535 · Cited by 68
Mineralocorticoid receptor activation in obesity hypertension
Nagase, M., & Fujita, T. (2009) · Hypertension Research · doi:10.1038/hr.2009.86 · Cited by 72
Le Barz, M., Daniel, N., Varin, T. V., Naimi, S., Demers‐Mathieu, V., Pilon, G., Audy, J., Laurin, É., Roy, D., Urdaci, M. C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801672r · Cited by 63
Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome
Palomo, I. F., Contreras, A., Alarcón, M. A., Elba Leiva, M., Guzmán, L., Mujica, V., Icaza, G., Díaz, N. S., González, D. R., & Moore‐Carrasco, R. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.03.002 · Cited by 63
“The metabolic syndrome (MS) is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance, and increased risk of developing cardiovascular diseases and diabetes [1].”
BackgroundAndré, A., & Gonthier, M. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.002 · Cited by 72
Abdominal obesity and mortality: The Pennington Center Longitudinal Study
Katzmarzyk, P. T., Mire, E. F., & Bouchard, C. (2012) · Nutrition and Diabetes · doi:10.1038/nutd.2012.15 · Cited by 63
Xu, N., Chu, J., Wang, M., Chen, L., Zhang, L., Xie, Z., Zhang, J., Ho, C., Li, D., & Wan, X. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00138 · Cited by 64
Langner, T., Hedström, A., Mörwald, K., Weghuber, D., Forslund, A., Bergsten, P., Ahlström, H., & Kullberg, J. (2018) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27550 · Cited by 68
“Abdominal obesity has been linked to conditions such as hypertension, inflammation and type 2 diabetes and is increasingly prevalent even among young adults and children [1].”
BackgroundZhang, J., Zhao, L., Cheng, Q., Ji, B., Yang, M., Sanidad, K. Z., Wang, C., & Zhou, F. L. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03574 · Cited by 65
Peng, Y., Sun, Q., Xu, W., He, Y., Jin, W., Yuan, L., & Gao, R. (2019) · Food & Function · doi:10.1039/c9fo00148d · Cited by 67
Schwenzer, N. F., Machann, J., Schraml, C., Springer, L., Ludescher, B., Stefan, N., Häring, H. U., Fritsche, A., Claussen, C. D., & Schick, F. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181f10fe1 · Cited by 71
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
“However, in unhealthy or IR adipose tissue, the excess energy will be deposited in VAT and a variety of organs including muscle tissue [147, 148].”
BackgroundRahimlou, M., Mirzaei, K., Keshavarz, S. A., & Hossein‐Nezhad, A. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.09.015 · Cited by 65
“In the recent decades, following the industrial developments of countries, various factors particularly sedentary life style and western dietary patterns have led to a rise in prevalence of obesity and obesity-related chronic diseases such as some kinds of cancers, type 2 diabetes and other metabolic disorders [1,2].”
BackgroundInfluentialWang, M., Gao, B. Z., & Huang, F. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02668-x · Cited by 62
“Visceral fat accumulation produces inflammatory factors and free fatty acids, further exacerbating insulin resistance [33, 34].”
Gangloff, A., Bergeron, J., Pelletier-Beaumont, É., Nazare, J., Smith, J. D., Borel, A., Lemieux, I., Tremblay, A., Poirier, P., Alméras, N., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.118 · Cited by 63
Self-citationCha, Y., Park, Y., Lee, M., Chae, S., Park, K., Kim, Y. S., & Lee, H. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.2877 · Cited by 66
Gregersen, N. T., Bitz, C., Krog-Mikkelsen, I., Hels, O., Kovacs, E. M. R., Rycroft, J. A., Frandsen, E., Mela, D. J., & Astrup, A. (2009) · British Journal of Nutrition · doi:10.1017/s0007114509371779 · Cited by 61
Suzuki, T., Kumazoe, M., Kim, Y., Yamashita, S., Nakahara, K., Tsukamoto, S., Sasaki, M., Hagihara, T., Tsurudome, Y., Huang, Y., et al. (2013) · Scientific Reports · doi:10.1038/srep02749 · Cited by 64
“Mice were assigned to six groups: (1) a negative control group (control) fed a AIN93G diet; (2) a positive control group (HF/HS) fed a high-fat/high-sucrose diet; (3) a group (Yabukita 0.”
MethodMain characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes
Teixeira, T. F., Alves, R. D. M., Moreira, A. P. B., & Pelúzio, M. D. C. G. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu007 · Cited by 68
Population-based evaluation of the‘LiveLighter’ healthy weight and lifestyle mass media campaign
Morley, B., Niven, P., Dixon, H., Swanson, M. G., Szybiak, M., Shilton, T., Pratt, I., Slevin, T. J., Hill, D., & Wakefield, M. A. (2016) · Health Education Research · doi:10.1093/her/cyw009 · Cited by 70
Mi, Y., Qi, G., Gao, Y.-Q., Li, R., Wang, Y., Li, X., Huang, S., & Liu, X. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700440 · Cited by 62
Zuliani, G., Volpato, S., Galvani, M., Blè, A., Bandinelli, S., Corsi, A. M., Lauretani, F., Maggio, M. G., Guralnik, J. M., Fellin, R., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.038 · Cited by 73
“As proposed by Depres & Lemieux in the “overflow-ectopic fat” model [36], when extra energy (resulting from excess intake and sedentary life style) is not channeled to insulin-sensitive subcutaneous adipose tissue, it would be deposited at undesiderable sites such as liver, heart, and skeletal muscle, and visceral fat.”
The effects of whey protein with or without carbohydrates on resistance training adaptations
Hulmi, J. J., Laakso, M., Mero, A. A., Häkkinen, K., Ahtiainen, J. P., & Peltonen, H. (2015) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-015-0109-4 · Cited by 61
“Conversely, excessive fat, especially in the abdominal area, is linked to increased risk of premature death [4] and comorbidities such as negatively altered blood lipid profile [5].”
BackgroundGenetic Variation at the FTO Locus Influences RBL2 Gene Expression
Jowett, J. B. M., Curran, J. E., Johnson, M. P., Carless, M. A., Göring, H. H. H., Dyer, T. D., Cole, S. A., Comuzzie, A. G., MacCluer, J. W., Moses, E. K., et al. (2010) · Diabetes · doi:10.2337/db09-1277 · Cited by 61
Murdolo, G., Bartolini, D., Tortoioli, C., Piroddi, M., Iuliano, L., & Galli, F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.007 · Cited by 62
Honek, J., Seki, T., Iwamoto, H., Fischer, C., Li, J., Lim, S., Samani, N. J., Zang, J., & Cao, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415825111 · Cited by 60
Maïmoun, L., Lefebvre, P., Jaussent, A., Fouillade, C., Mariano‐Goulart, D., & Nocca, D. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.01.017 · Cited by 65
Choe, E. K., Rhee, H., Lee, S. J., Shin, E., Oh, S., Lee, J.-E., & Choi, S. H. (2018) · Genomics & Informatics · doi:10.5808/gi.2018.16.4.e31 · Cited by 63
“that are known to be closely related to clinical factors, such as aging [21], sex [22], abdominal obesity [11], physical activity [23], alcohol consumption [24], and smoking [25].”
BackgroundUchiyama, S., Sada, Y., Mihara, S., Sasaki, Y., Sone, M., & Tanaka, Y. (2023) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4987 · Cited by 52
“Excess body fat may be a major cause of insulin resistance and deterioration of glucose metabolism [1, 2].”
BackgroundAkter, S., Jesmin, S., Rahman, M. M., Islam, M. M., Khatun, M. T., Yamaguchi, N., Akashi, H., & Mizutani, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068319 · Cited by 66
“Thirdly, repeated pregnancies cause excess gain in weight, weight variability or weight cycling [27,28], and will led to greater upper fat distribution and a higher prevalence of metabolic syndrome [29,30].”
BackgroundAdditional role of sarcopenia to waist circumference in predicting the odds of metabolic syndrome
Park, S. H., Park, J. H., Park, H. Y., Jang, H. J., Kim, H. K., Park, J., Shin, K. J., Lee, J. G., & Moon, Y. S. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.08.008 · Cited by 61
Imig, J. D., Walsh, K., Khan, A. H., Nagasawa, T., Shaw, M. C., Shaw, S. M., & Hammock, B. D. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012225 · Cited by 61
The Multiple Facets of the Fat Tissue
Rocha, V. Z., & Libby, P. (2008) · Thyroid · doi:10.1089/thy.2007.0296 · Cited by 59
Shakeri-Manesch, S., Zeyda, M., Huber, J. C., Ludvik, B. H., Prager, G., & Stulnig, T. M. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.160 · Cited by 64
Role of developmental transcription factors in white, brown and beige adipose tissues
Hilton, C., Karpe, F., & Pinnick, K. E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.02.003 · Cited by 68
Associations of birthweight and infant growth with body composition at age 15 – the COMPASS study
Eriksson, M., Tynelius, P., & Rasmussen, F. E. (2008) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2008.00944.x · Cited by 61
Iwen, K. A. H., Senyaman, O., Schwartz, A., Drenckhan, M., Meier, B., Hadaschik, D., & Klein, J. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0299 · Cited by 62
“There is growing evidence for an implication of adipose dysfunction critically promoting the development of this syndrome and its complications (Despres & Lemieux 2006).”
BackgroundLac, G., Cavalie, H., Ebal, E., & Michaux, O. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-16 · Cited by 61
“More specifically, the visceral fat, which was already pointed out as a reliable marker of insulin resistance, in humans [21, 22 ] seems to present the same deleterious effects on bone.”
The role of obesity in gastrointestinal cancer: evidence and opinion
Donohoe, C. L., O’Farrell, N. J., Doyle, S. L., & Reynolds, J. V. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x13501786 · Cited by 69
“Visceral adipose tissue secretes a number of adipokines and cytokines leading to a pro-inflammatory, procoagulant and insulin-resistant state collectively known as metabolic syndrome [Despres and Lemieux, 2006] (Figure 1).”
BackgroundSoresi, M., Noto, D., Cefalu, A. B., Martini, S., Vigna, G. B., Fonda, M., Manzato, E., Cattin, L., Fellin, R., Averna, M. R., et al. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0406-1 · Cited by 66
“According to the ‘‘ectopic lipid overflow-fat model,’’ ectopic fat could not only trigger insulin resistance, but could also accelerate all those metabolic/ inflammatory changes that drive the progression from simple steatosis to more severe forms of liver diseases [41].”
BackgroundShahi, M. M., Zakerzadeh, M., Zakerkish, M., Zarei, M., & Saki, A. (2016) · Journal of Dietary Supplements · doi:10.1080/19390211.2016.1204404 · Cited by 61
“Development of T2DM is intimately in association with obesity, especially abdominal obesity and predominantly visceral fat (Chan et al., 1994; Despres & Lemieux, 2006).”
BackgroundFructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome
Legeza, B., Marcolongo, P., Gamberucci, A., Varga, V., Bánhegyi, G., Benedetti, A., & Odermatt, A. (2017) · Nutrients · doi:10.3390/nu9050426 · Cited by 68
“The involvement of adiposity—predominantly splanchnic obesity—in the development of the metabolic syndrome (MetS) has been well established [7].”
BackgroundFacial Adiposity, Attractiveness, and Health: A Review
de Jager, S., Coetzee, N., & Coetzee, V. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02562 · Cited by 64
Sarin, H. V., Lee, J. H., Jauhiainen, M., Joensuu, A., Borodulin, K., Männistö, S., Jin, Z., Terwilliger, J. D., Isola, V., Ahtiainen, J. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40107-6 · Cited by 68
Wu, B., Fukuo, K., Suzuki, K., Yoshino, G., & Kazumi, T. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-332 · Cited by 66
“OBESITY is the principle causative factor and main component of metabolic syndrome (MetS) [1].”
BackgroundA-FABP in Metabolic Diseases and the Therapeutic Implications: An Update
Li, H., Wu, X., Xu, A., & Hoo, R. L. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179386 · Cited by 62
“Sci. 2021, 22, 9386 10 of 22 Abbreviations used in Table 2: A-FABP, adipocyte-fatty acid binding protein; CIMT, carotid intima-media thickness; CAD, coronary artery disease; BMI, body mass index; IL-6, Interleukin-6; hsCRP, high-sensitive C-reactive protein; HDL, high-density lipoprotein; CVD, cardiovascular disease.”
BackgroundInfluentialChapter 4 Melanocortin‐4 Receptor Mutations In Obesity
Santini, F., Maffei, M., Pelosini, C., Salvetti, G., Scartabelli, G., & Pinchera, A. (2009) · Advances in clinical chemistry · doi:10.1016/s0065-2423(09)48004-1 · Cited by 72
Harrington, D. M., Staiano, A. E., Broyles, S. T., Gupta, A., & Katzmarzyk, P. T. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00106.x · Cited by 60
Biomarkers in the field of obesity and its related comorbidities
Katsareli, E. A., & Dedoussis, G. V. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.882321 · Cited by 70
“TNF-a is a pro-inflammatory cytokine, and it was the first adipocyte-derived factor that suggested a link between obesity, inflammation and T2DM [72].”
BackgroundInfluentialNazare, J., Smith, J. D., Borel, A., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., & Després, J. (2013) · Journal of Nutrition · doi:10.3945/jn.113.175273 · Cited by 65
Self-citationFox, K. A. A., Després, J., Richard, A., Brette, S., & Deanfield, J. E. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp371 · Cited by 72
“The increased CVD risk with an elevated WC is likely to result, at least in part, from excess visceral adiposity, the latter being predictive of insulin resistance and of an atherogenic, pro-thrombotic, and inflammatory profile.(17) Thus, despite marked differences in the background prevalence of CVD across European r…”
BackgroundSelf-citationInsulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
Eisenstein, S. A., Gredysa, D. M., Antenor–Dorsey, J. A., Green, L., Arbeláez, A. M., Koller, J. M., Black, K. J., Perlmutter, J. S., Moerlein, S. M., & Hershey, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133621 · Cited by 54
“Human obesity is associated with altered dopamine (DA) function [1], altered DA D2-like receptor binding in brain reward regions [2–3], altered reward-related behavior [4–6], and insulin dysregulation [7–8].”
BackgroundShum, M., Pinard, S., Guimond, M., Labbé, S. M., Roberge, C., Baillargeon, J., Langlois, M., Alterman, M., Wallinder, C., Hallberg, A., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00149.2012 · Cited by 62
“Therefore, an understanding of the specific properties and regulation of visceral (dysfunctional TG storage) as opposed to SC (functional TG storage) adipose tissues is of paramount importance (8, 15, 23).”
BackgroundLanzi, C. R., Perdicaro, D. J., Antoniolli, A., Fontana, A., Miatello, R. M., Bottini, R., & Prieto, M. A. V. (2016) · Food & Function · doi:10.1039/c5fo01065a · Cited by 63
Fowke, J. H., Koyama, T., Fadare, O., & Clark, P. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156918 · Cited by 64
Dragsbæk, K., Neergaard, J. S., Moll, J. M., Hansen, H. B., Christiansen, C., Beck‐Nielsen, H., Karsdal, M. A., Brix, S., & Henriksen, K. (2016) · Medicine · doi:10.1097/md.0000000000004806 · Cited by 74
Gogg, S., Nerstedt, A., Borén, J., & Smith, U. (2019) · JCI Insight · doi:10.1172/jci.insight.125914 · Cited by 64
Chimenti, M. S., Fonti, G. L., Conigliaro, P., Sunzini, F., Scrivo, R., Navarini, L., Triggianese, P., Peluso, G., Scolieri, P., Caccavale, R., et al. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1761957 · Cited by 60
“MetS was investigated in accordance with internationally recognized standards [20].”
MethodAbdominal obesity and metabolic syndrome in South Asians: prevention and management
Jayawardena, R., Sooriyaarachchi, P., & Misra, A. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1982381 · Cited by 62
“Moreover, an impaired non-esterified fatty acid metabolism contributes to the insulin-resistant state observed among individuals with visceral obesity [7].”
BackgroundAngiotensin 1–7: A peptide for preventing and treating metabolic syndrome
Santos, S. H. S., & Andrade, J. M. O. (2014) · Peptides · doi:10.1016/j.peptides.2014.07.002 · Cited by 60
“Some studies indicated that the systemic elevation of Ang –7 in rats increases insulin-induced glucose removal in isolated dipocytes [22]; whereas, in adipocytes from MasR deficient mice ecrease insulin-dependent glucose transport [23].”
BackgroundKolehmainen, M., Ulven, S. M., Paananen, J., de Mello, V., Schwab, U., Carlberg, C., Myhrstad, M., Pihlajamäki, J., Dungner, E., Sjölin, E., et al. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.092783 · Cited by 54
Radmard, A. R., Merat, S., Kooraki, S., Ashrafi, M., Keshtkar, A., Sharafkhah, M., Jafari, E., Malekzadeh, R., & Poustchi, H. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30765-3 · Cited by 68
Choi, J., Pichiah, P. B. T., Kim, M., & Cha, Y. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-30 · Cited by 59
Lee, Y., Cha, Y.-S., Park, Y., & Lee, M. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3911 · Cited by 58
“With the epidemics of obesity and diabetes growing around the world, the role of functional diets or foods on obesity management is an area of intense research.(1,2) Soybean contains significant amounts of phytate, w-3 fatty acids, isoflavone, polyphenols, and saponins, which serve many biological functions such as an…”
Modulation of Vascular Reactivity by Perivascular Adipose Tissue (PVAT)
Rosei, C. A., Paini, A., Ciuceis, C. D., Withers, S., Greenstein, A. S., Heagerty, A. M., & Rizzoni, D. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0835-5 · Cited by 66
Obesity is associated with shorter telomeres in 8 year-old children
Clemente, D. B. P., Maître, L., Bustamante, M., Chatzi, L., Roumeliotaki, T., Fossati, S., Gražulevičienė, R., Gützkow, K. B., Lepeule, J., Martens, D. S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55283-8 · Cited by 64
Sánchez‐González, C., Nuevo‐Tapioles, C., Martín, J. C. H., Pereira, M. P., Sanz, S. S., de Molina, A. R., Cuezva, J. M., & Formentini, L. (2020) · The EMBO Journal · doi:10.15252/embj.2019103812 · Cited by 60
“Although the implication of BCAA metabolism and reductive carboxylation in the setting of IR is still object of debate, the connection between the ectopic accumulation of lipids and impaired glycemic control has been widely documented (Despres & Lemieux, 2006).”
Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
Asfari, M. M., Sarmini, M. T., Baidoun, F., Al‐Khadra, Y., Ezaizi, Y., Dasarathy, S., & McCullough, A. J. (2020) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000352 · Cited by 65
Hsieh, Y., Joo, S. K., Koo, B. K., Lin, H., & Kim, W. (2021) · Liver International · doi:10.1111/liv.14719 · Cited by 55
Haverinen, E., Paalanen, L., Palmieri, L., Padrón‐Monedero, A., Noguer-Zambrano, I., Sarmiento-Suárez, R., Tolonen, H. K., & (InfAct), F. T. J. A. O. H. I. (2021) · Archives of Public Health · doi:10.1186/s13690-021-00749-3 · Cited by 65
“In this study population, central obesity was highly prevalent among both men and women, similarly to other European populations [21, 23, 41].”
ResultHuang, H., Zheng, X., Wen, X., Zhong, J., Zhou, Y., & Xu, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1144834 · Cited by 64
Fan, H., Wang, Y., Ren, Z., Liu, X., Zhao, J., Yuan, Y., Fei, X., Song, X., Wang, F., & Liang, B. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01052-7 · Cited by 64
“After discovering that IR deficiency alone could not account for the onset of cardiovascular disease in individuals of all body types, researchers turned their attention to visceral fat, which was discovered to have a positive correlation with IR and blood lipid levels in both overweight and obese populations [5].”
BackgroundZhu, X., Dai, X., Zhao, L., Li, J., Zhu, Y., He, W., Guan, X., Wu, T., Liu, L., Song, H., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2390136 · Cited by 60
“27,37 The detrimental impact of abdominal obesity on diseases such as diabetes and cardiovascular diseases surpasses that of general obesity.”
BackgroundMethodIda, M., Hirata, M., Odori, S., Mori, E., Kondo, E., Fujikura, J., Kusakabe, T., Ebihara, K., Hosoda, K., & Nakao, K. (2013) · Obesity · doi:10.1002/oby.20300 · Cited by 57
Prevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis
Merlotti, C., Morabito, A., Ceriani, V., & Pontiroli, A. E. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0624-9 · Cited by 64
Borel, A., Nazare, J., Smith, J. D., Aschner, P. J., Barter, P. J., Gaal, L. V., Tan, C., Wïttchen, H., Matsuzawa, Y., Kadowaki, T., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.163 · Cited by 58
Self-citationBaumgartner, R. R., Steinmann, D., Heiß, E. H., Atanasov, A. G., Ganzera, M., Stuppner, H., & Dirsch, V. M. (2010) · Journal of Natural Products · doi:10.1021/np100258e · Cited by 60
Interleukin-1 beta: a potential link between stress and the development of visceral obesity
Speaker, K. J., & Fleshner, M. (2012) · BMC Physiology · doi:10.1186/1472-6793-12-8 · Cited by 68
“Evidence also conversely demonstrates that a reduced ratio of visceral fat mass relative to non-visceral fat mass is correlated with reduced disease risk [23,24].”
BackgroundKim, T. H., Yu, S. H., Choi, S. H., Yoon, J. W., Kang, S. M., Chun, E. J., Choi, S. I., Shin, H., Lee, H. K., Park, K. S., et al. (2010) · Obesity · doi:10.1038/oby.2010.246 · Cited by 58
“A Bland–Altman analysis that validate the two methods showed that only 6 out of 402 (1.49”
MethodInfluentialInsulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk
Turco, S. D., Gaggini, M., Daniele, G., Basta, G., Folli, F. B., Sicari, R., & Gastaldelli, A. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319130010 · Cited by 65
Differential Effects of Bariatric Surgery Versus Exercise on Excessive Visceral Fat Deposits
Wu, F.-Z., Huang, Y.-L., Wu, C. C., Wang, Y.-C., Pan, H.-J., Huang, C.-K., Yeh, L.-R., & Wu, M.-T. (2016) · Medicine · doi:10.1097/md.0000000000002616 · Cited by 55
Development of Early Adiposity in Infants of Mothers With Gestational Diabetes Mellitus
Logan, K. M., Emsley, R. J., Jeffries, S., Andrzejewska, I., Hyde, M. J., Gale, C., Chappell, K., Mandalia, S., Santhakumaran, S., Parkinson, J. R. C., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0030 · Cited by 57
“Internal abdominal AT is associated with higher metabolic risk (9), whereas abdominal or nonabdominal superficial subcutaneous AT may be protective (10).”
BackgroundLi, W., Wang, Y., Shen, L., Song, L., Liu, B., Liu, B., Yuan, J., & Wang, Y. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0133-7 · Cited by 64
“When the ability of adipose tissue to store the excess energy is limited due to insulin resistance, the triacylglycerol surplus is deposited at undesirable sites such as visceral adipose tissue [34].”
BackgroundOhta, A., Kato, H., Ishii, S., Sasaki, Y., Nakamura, Y., Nakagawa, T., Nagai, Y., & Tanaka, Y. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1363888 · Cited by 56
Impact of Adrenal Steroids on Regulation of Adipose Tissue
Infante, M., Armani, A., Mammi, C., Fabbri, A., & Caprio, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160037 · Cited by 60
Rost, S., Freuer, D., Peters, A., Thorand, B., Holle, R., Linseisen, J., & Meisinger, C. (2018) · BMC Public Health · doi:10.1186/s12889-018-5350-8 · Cited by 64
“As underlying mechanisms for the higher mortality risk associated with a visceral fat accumulation, particularly in women, a number of different causes are suggested [32, 33].”
BackgroundKoebnick, C., Black, M. H., Wu, J., Shu, Y., MacKay, A. W., Watanabe, R. M., Buchanan, T. A., & Xiang, A. H. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518002726 · Cited by 61
“Obesity is a disorder of the energy homeostasis system; the mechanisms to regulate and defend excess body weight are currently not well understood and involve several adipokines((37,38)).”
Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK
Kim, K.-D., Jung, H., Ryu, H. G., Kim, B., Jeon, J., Hyunju, Y. O. O., Park, C. H., Choi, B.-H., Hyun, C., Kim, K., et al. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.12.001 · Cited by 62
The Dual Role of the Pervasive “Fattish” Tissue Remodeling With Age
Conte, M., Martucci, M., Sandri, M., Franceschi, C., & Salvioli, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00114 · Cited by 62
“Higher levels of circulating FFA lead to lipotoxicity and the development of metabolic disorders (31, 32).”
BackgroundMinireview: Circadian Control of Metabolism by the Suprachiasmatic Nuclei
Kalsbeek, A., Kreier, F., Fliers, E., Sauerwein, H. P., Romijn, J. A., & Buijs, R. M. (2007) · Endocrinology · doi:10.1210/en.2007-0776 · Cited by 58
“Excessive intraabdominal fat is far worse than excessive sc fat, due to its much stronger association with the metabolic syndrome and type 2 diabetes (37).”
Kogiso, T., Moriyoshi, Y., Shimizu, S., Nagahara, H., & Shiratori, K. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0002-5 · Cited by 60
Type 2 diabetes and cardiovascular disease: what next?
Joseph, J. J., & Golden, S. H. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000044 · Cited by 57
The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis
Mouchiroud, M., Camiré, É., Aldow, M., Caron, A., Jubinville, É., Turcotte, L., Kaci, I., Beaulieu, M.-J., Roy, C., Labbé, S. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129492 · Cited by 57
Ectopic visceral fat: A clinical and molecular perspective on the cardiometabolic risk
Mathieu, P., Boulanger, M., & Després, J. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9299-3 · Cited by 61
“[2] To this effect, the accumulation of visceral ectopic fat along with its key metabolic perturbations is now considered as a key modifiable CVD risk factor, which contributes to exacerbate CVD risk beyond classical risk factors.[3] Ectopic visceral fat is associated with a plethora of metabolic abnormalities, which…”
BackgroundSelf-citationMukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 67
Obesity and Chronic Obstructive Pulmonary Disease: Is Fatter Really Better?
Galesanu, R. G., Bernard, S., Marquis, K., Lacasse, Y., Poirier, P., Bourbeau, J., & Maltais, F. (2014) · Canadian Respiratory Journal · doi:10.1155/2014/181074 · Cited by 66
Hsieh, C., Rau, C., Wu, S., Yang, J. C., Wu, Y.-C., Lu, T., Tzeng, S.-L., Wu, C., & Lin, C.-W. (2015) · BMC Genomics · doi:10.1186/s12864-015-1896-3 · Cited by 59
“White adipose tissue (WAT) has been characterized as an endocrine organ [3], as it produces endocrineacting peptides such as leptin, and it is metabolically important, with excess levels being associated with metabolic syndrome [4, 5].”
BackgroundDurmuş, B., Mook-Kanamori, D. O., Holzhauer, S., Hofman, A., van der Beek, E. M., Boehm, G., Steegers, E. A. P., & Jaddoe, V. W. V. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03708.x · Cited by 64
Kim, D., Kim, M., Sa, B.-K., Kim, M., & Hwang, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13010994 · Cited by 61
Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity
Smith, S. R., Fujioka, K., Gupta, A. K., Billes, S. K., Burns, C., Kim, D., Dunayevich, E., & Greenway, F. L. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12095 · Cited by 55
“Central adiposity, especially visceral adipose tissue (VAT), is associated with elevated risk for cardiometabolic morbidity and mortality independent of total adipose tissue [1].”
Background
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.